At DNAQ, we are following all current advice provided by the Australian Government, local health authorities and the World Health Organization (WHO), and taking extra precautionary steps to ensure the health and safety of our laboratory staff and customer service team to minimise any disruption to testing
Please be advised our laboratory is still operational, and we are currently not experiencing any delays with processing of samples.
For all non-legal testing, a testing kit can be sent directly to your home address. You can simply collect the sample yourself at home, and post it back to DNAQ in the supplied prepaid return envelope. Legal Collection appointments are also still available at our laboratory in Brisbane upon request. However, if you are experiencing any virus-like symptoms or have travelled overseas in the past 14 days, we recommend delaying your collection or rescheduling your appointment to a later date.
If you have any questions or concerns, please don’t hesitate to contact our friendly staff on 1300 172 837.
DNAQ is proud to offer a range of Clinical and Oncology Testing options through our partner laboratory, Genomics For Life.
Genomics For Life Pty Ltd is a private pathology laboratory specialising in genomic testing. We offer compassionate and professional testing services, aiming to provide an innovative synergy between state-of-the-art technology and genetic expertise.
At Genomics For Life, we use next generation sequencing (NGS) technologies, amongst other techniques, to evaluate patients’ genomic profiles. This allows us to give the most accurate diagnosis and allow patients to benefit from personalised medicine and treatments in a range of areas, including:
Please see below our range of testing options, or visit our website for more information.
Each tumour has a unique genetic makeup, even amongst cancers of the same tissue type. Genomic testing can be used to analyse the DNA of your tumour and may identify the genetic mutations that are unique to your cancer.
Identifying the mutations in a patient’s cancer is the key to developing personalised treatments. Depending on the type of testing done, a comprehensive genomic analysis may provide information on potential therapeutics, development of resistant to treatments, prognosis, disease tracking, and may provide access to clinical trials or new treatments that were not available at the time of diagnosis.
We offer a wide range of testing options. As each patient’s case is unique, there is no “one size fits all” when it comes to testing. We encourage you to contact Genomics For Life regarding testing and pricing, and we can work with you and your oncologist/specialist, to determine what tests would benefit you.
Genomics For Life has one of the largest genetic testing options of any laboratory in Australia. Our testing range covers over 3,000 genes associated with a whole range of inherited disorders. Some common inherited disorders we test for include Cystic Fibrosis, BRCA Gene Testing and other Inherited Cancers, Wilson’s Disease, Noonan Syndrome, Stickler Syndrome and Ehlers-Danlos Syndrome.
The Pharmacogenomics test is your one test for life. The test will cover your metabolic response to medications at all stages in life, and can be referred back to at any time regardless of your age or health status. Pharmacogenomics is the analysis of how genes affect a person’s response to drugs. As everyone has a unique genetic makeup, this can affect how you will respond or react to certain medications. Through pharmacogenomics testing, individualised medicine treatment plans can be developed based on each patient’s genetic makeup, to determine optimal drugs and dosages, and limit harmful side effects.
NIFTYTM is a highly accurate, Non-Invasive Prenatal Screening (NIPS) for chromosomal abnormalities. NIFTYTM uses a blood sample from the pregnant mother to analyse the fetal DNA for chromosomal conditions including trisomies, such as Down Syndrome and Edwards Syndrome, Sex Chromosomal Aneuploidies and Deletion/Duplication Syndromes.
NOVATM is a newborn genetic screening test that can determine a baby’s risk for 87 inherited disorders, as well as providing personalised genetic information on their likely response to 32 commonly administered paediatric drugs. It is the most comprehensive and accurate newborn screening test on the market, with over 99% accuracy. Testing may be completed using a non-invasive cheek swab, that is painless and risk free for your child.
Site Design, SEO, SEM and Management by Optimised